One everyday activity is practically pitch perfect when it comes to delaying dementia. US cases are predicted to double by 2060, with about half of Americans expected to experience cognitive ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring ...

Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...

Dr. Peter Attia has declared war on what he calls the marginal decade, the final years of life that are often plagued by ...

Specially qualified nurses with extended roles—known as Dementia Care Managers—can measurably improve the care of people with ...

Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT ...

In Houston, a 91-year-old sings to his wife of 66 years, while in Louisiana, a 9-year-old raises money for her sister with ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...

Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...